Journal
ANTIOXIDANTS
Volume 12, Issue 2, Pages -Publisher
MDPI
DOI: 10.3390/antiox12020367
Keywords
sulfiredoxin; peroxiredoxin; lung cancer; tumorigenesis
Ask authors/readers for more resources
Non-small cell lung cancer (NSCLC) is associated with smoking, which causes oxidative stress and promotes the occurrence of mutations and aberrant signaling pathways. Knockout of the Srx-Prx4 axis reduces the number and size of lung tumors in mice, inhibits cell proliferation, and decreases intra-tumoral macrophage infiltration.
Non-small cell lung cancer (NSCLC), the most common type of lung cancer, etiologically associates with tobacco smoking which mechanistically contributes to oxidative stress to facilitate the occurrence of mutations, oncogenic transformation and aberrantly activated signaling pathways. Our previous reports suggested an essential role of Sulfiredoxin (Srx) in promoting the development of lung cancer in humans, and was causally related to Peroxiredoxin IV (Prx4), the major downstream substrate and mediator of Srx-enhanced signaling. To further explore the role of the Srx-Prx4 axis in de novo lung tumorigenesis, we established Prx4(-/-) and Srx(-/-)/Prx4(-/-) mice in pure FVB/N background. Together with wild-type litter mates, these mice were exposed to carcinogenic urethane and the development of lung tumorigenesis was evaluated. We found that disruption of the Srx-Prx4 axis, either through knockout of Srx/Prx4 alone or together, led to a reduced number and size of lung tumors in mice. Immunohistological studies found that loss of Srx/Prx4 led to reduced rate of cell proliferation and less intratumoral macrophage infiltration. Mechanistically, we found that exposure to urethane increased the levels of reactive oxygen species, activated the expression of and Prx4 in normal lung epithelial cells, while knockout of Prx4 inhibited urethane-induced cell transformation. Moreover, bioinformatics analysis found that the Srx-Prx4 axis is activated in many human cancers, and their increased expression is tightly correlated with poor prognosis in NSCLC patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available